...with 59% of workers’ comp patients saying they would recommend their providers, as compared to 79% of non-workers’ comp patients.3 And a recent Healthesystems’ study found that 60% of patients who...
...with 59% of workers’ comp patients saying they would recommend their providers, as compared to 79% of non-workers’ comp patients.3 And a recent Healthesystems’ study found that 60% of patients who...
...new report that searched nine medical literature databases for randomized controlled trials comparing synthetic and natural cannabinoids to placebo in patients with neuropathic pain syndromes. Eight trials were found and...
The FDA has recently issued two separate communications regarding semaglutide – a drug gaining strong popularity for weight loss – noting concerns with compounded semaglutide, as well as reports of...
The DEA announced plans to facilitate and expand scientific and medical research for marijuana, with plans to bolster the marijuana growers program, allowing for a greater wealth of marijuana research. New...
...workplace drug tests for employers – released findings from their 2024 Drug Testing Index, based on approximately 5.5. million urine drug samples. The report found that marijuana positivity in the...
When developing effective claims programs for workers’ comp, a finely tuned user research process is a crucial tool in ensuring that stakeholders across the board all benefit from the solutions...
...affects different aspects of the workers’ comp ecosystem (see our blog, How Inflation is Affecting Transportation). Next, we’re examining the effect on home healthcare. Home healthcare can be particularly important...
...Waltemath has spent over 10 years in the workers’ comp industry, applying her diverse clinical and analytical skills in the development and support of programs that improve the injured worker’s...
...comp claim populations are due to a combination of factors and efforts at federal, state, and individual program levels championed by workers’ compensation payers and PBMs. As we have seen...
The Justice Department announced a global resolution of criminal and civil investigations with Purdue Pharma. Pleading guilty, Purdue faces a settlement that involves more than $8 billion, the dissolution of the company,...
